Development and Multicenter Validation of a Novel Bio-Anatomical Staging System for Predicting Survival and Tailoring Adjuvant Therapy in ESCC After Neoadjuvant Chemoimmunotherapy.
NCT07488624
·
clinicaltrials.gov ↗
COMPLETED
Status
414
Enrollment
OTHER
Sponsor class
Conditions
ESCC
Sponsor
Sichuan University